Walgreens Boots Alliance, Inc.

    Walgreens Boots Alliance, Inc.

    NNASDAQ:WBA
    - -
    USD
    - -
    - -
    2012 Y
    2013 Y
    2014 Y
    2015 Y
    2016 Y
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    TTM
    Revenue per Share
    81.89
    76.34
    80.15
    99.16
    108.35
    110.12
    132.73
    130.3
    138.71
    153.23
    153.52
    161.12
    171.08
    178.89
    Basic EPS, GAAP
    2.43
    2.69
    2.03
    4.05
    3.85
    3.8
    5.07
    4.32
    0.52
    2.94
    5.02
    -3.57
    -10.01
    -7.29
    Free Cash Flow per Basic Share
    3.29
    3.27
    2.92
    4.23
    6.02
    5.5
    6.96
    4.22
    4.67
    4.83
    2.5
    0.16
    -0.42
    0.67
    Dividend per Share
    0.9
    1.1
    1.26
    1.33
    1.44
    1.61
    1.75
    1.78
    1.99
    1.87
    1.92
    1.92
    1.46
    0.75
    Book Value per Share
    23.13
    22.84
    23.51
    24.06
    25.57
    28.08
    33.87
    38.88
    38.92
    40.63
    43.74
    38.31
    27.07
    22.96
    Tangible Book Value per Share
    16.91
    16.64
    17.92
    2.47
    4.11
    2.32
    -2.03
    -3.56
    -1.08
    2.06
    -3.01
    -15.44
    -18.88
    -17.83
    Basic Weighted Avg Shares
    875
    946
    953
    1,043
    1,083
    1,074
    991
    922
    879
    865
    864
    863
    863
    864
    Sales/Revenue/Turnover
    71,633
    72,217
    76,392
    103,444
    117,351
    118,214
    131,537
    120,074
    121,982
    132,509
    132,703
    139,081
    147,658
    154,580
    Operating Margin (%)
    4.84
    4.95
    4.68
    4.21
    5.08
    4.52
    4.64
    3.83
    0.53
    2.63
    0.73
    -5.13
    -1.08
    -1.86
    Depreciation Expense
    1,166
    1,283
    1,316
    1,742
    1,718
    1,654
    1,770
    2,038
    1,927
    1,973
    1,990
    2,257
    2,459
    2,431
    Net Income, GAAP
    2,127
    2,548
    1,932
    4,220
    4,173
    4,078
    5,024
    3,982
    456
    2,542
    4,337
    -3,080
    -8,636
    -6,298
    Effective Tax Rate (%)
    37
    37.04
    42.9
    19.88
    19.38
    15.66
    16.7
    13.24
    76.01
    33.43
    - -
    - -
    - -
    - -
    Profit Margin (%)
    2.97
    3.53
    2.53
    4.08
    3.56
    3.45
    3.82
    3.32
    0.37
    1.92
    3.27
    -2.21
    -5.85
    -4.07
    Working Capital
    2,038
    2,991
    3,347
    3,100
    8,870
    1,206
    -3,821
    -7,069
    -8,997
    -6,240
    -5,681
    -9,032
    -8,618
    -10,257
    LT Debt
    4,073
    4,477
    3,716
    13,315
    18,705
    12,684
    12,431
    11,098
    33,968
    29,829
    32,133
    30,269
    28,965
    26,172
    Total Equity
    18,236
    19,454
    20,617
    31,300
    30,281
    28,274
    26,689
    24,153
    21,135
    24,140
    30,408
    28,490
    12,181
    7,319
    Return on Invested Capital (%)
    10.56
    9.22
    8.18
    9.86
    10.12
    9.93
    12.25
    9.67
    0.3
    3.91
    - -
    - -
    - -
    - -
    Return on Capital (%)
    9.29
    10.15
    7.17
    13.88
    10.65
    10.19
    11.95
    8.96
    1
    4.42
    - -
    - -
    - -
    - -
    Return on Common Equity (%)
    10.85
    12.18
    8.78
    17.77
    15.81
    14.1
    15.77
    11.48
    1.3
    7.33
    11.89
    -8.69
    -30.61
    -27.2

    Capital Structure

    USD

    •

    in mil. unless spec.
    Aug'24
    Nov'25
    May'25
    ST Debt
    3,887
    2,835
    2,862
    LT Borrowings
    8,044
    7,611
    6,937
    LT Finance Leases
    20,921
    20,262
    19,235
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    864
    863
    865
    Market Capitalization
    7,750
    7,787
    9,721

    Working Capital

    USD

    •

    in mil. unless spec.
    Aug'24
    Nov'25
    May'25
    Total Current Assets
    18,335
    17,478
    15,701
    Cash, Cash Equivalents & STI
    3,109
    1,191
    830
    Accounts Receivable, Net
    5,851
    6,191
    5,500
    Inventories
    8,320
    9,119
    7,320
    Total Current Liabilities
    26,953
    27,453
    25,958
    Payables & Accruals
    23,067
    24,618
    23,096
    ST Debt
    3,887
    2,835
    2,862
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    -0.9%
    -7.17%
    -57.24%
    Free Cash Flow
    -42.2%
    -98.38%
    -357.45%
    Net Income, GAAP
    56.64%
    89.78%
    180.39%
    Sales/Revenue/Turnover
    7.35%
    4.27%
    6.17%
    Total Cash Common Dividend
    - -
    - -
    -24.05%

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    33,382
    34,862
    35,415
    35,422
    139,081
    2024
    36,707
    37,052
    36,351
    37,547
    147,658
    2025
    39,459
    38,588
    38,986
    - -
    - -

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    -4.31
    0.81
    0.14
    - -
    -3.57
    2024
    -0.08
    -6.85
    0.4
    -3.48
    -10.01
    2025
    -0.31
    -3.3
    -0.2
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    0.48
    0.48
    0.48
    - -
    1.92
    2024
    0.48
    0.48
    0.25
    0.25
    1.46
    2025
    0.25
    0.25
    - -
    - -
    - -

    Company Description

    Company Profile APIChatGPT
    Address
    Similar Companies
    Business

    Company News

    Company News APIChatGPT

    • etftrends.com

      A Sinking Ship or A Turnaround Bet

    • reuters.com

      US pharmacy chain Walgreens plans tech centre in India's Chennai, expected to create 250 jobs

    • businesswire.com

      Walgreens Pharmacists Help Medicare Patients Navigate New Access to GLP‑1 Medications

    • businesswire.com

      Walgreens Boosts Pharmacy Access with Expanded Hours on 4th of July

    • businesswire.com

      Walgreens Helps FIFA World Cup™ Fans in Seattle Stay Game-Ready with Pharmacy Care and Everyday Essentials

    • businesswire.com

      Walgreens Helps FIFA World Cup™ Fans in New York Stay Game-Ready with Pharmacy Care and Everyday Essentials

    • businesswire.com

      Walgreens Helps FIFA World Cup™ Fans in Philadelphia Stay Game-Ready with Pharmacy Care and Everyday Essentials

    • businesswire.com

      Walgreens Helps FIFA World Cup™ Fans in Dallas Stay Game-Ready with Pharmacy Care and Everyday Essentials

    • businesswire.com

      Walgreens Helps FIFA World Cup™ Fans in Miami Stay Game-Ready with Pharmacy Care and Everyday Essentials

    • businesswire.com

      Walgreens Helps FIFA World Cup™ Fans in Houston Stay Game-Ready with Pharmacy Care and Everyday Essentials

    • businesswire.com

      Walgreens Helps FIFA World Cup™ Fans in Los Angeles Stay Game-Ready with Pharmacy Care and Everyday Essentials

    • businesswire.com

      Walgreens Helps FIFA World Cup™ Fans in the Bay Area Stay Game-Ready with Pharmacy Care and Everyday Essentials

    • businesswire.com

      Walgreens Helps FIFA World Cup™ Fans in Atlanta Stay Game-Ready with Pharmacy Care and Everyday Essentials

    • businesswire.com

      Walgreens Helps FIFA World Cup™ Fans in Massachusetts Stay Game-Ready with Pharmacy Care and Everyday Essentials

    • businesswire.com

      Walgreens Helps FIFA World Cup™ Fans in Kansas City Stay Game-Ready with Pharmacy Care and Everyday Essentials

    • pymnts.com

      Walgreens Brings Hybrid Pharmacy Program to 6 States

    • businesswire.com

      Walgreens Virtual Healthcare Adds Weight Management Services to Support Patients on Their Weight Loss Journey

    • fastcompany.com

      Walgreens is laying off hundreds of workers, but its list of store closures in 2026 might not be as big as feared

    • reuters.com

      Walgreens cuts workforce after private equity buyout, Bloomberg News reports

    • gurufocus.com

      Market Today: Palantir beats, Disney warns; oil slides